Traders Buy Intuitive Surgical (ISRG) on Weakness

Investors bought shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) on weakness during trading hours on Thursday. $154.03 million flowed into the stock on the tick-up and $126.41 million flowed out of the stock on the tick-down, for a money net flow of $27.62 million into the stock. Of all equities tracked, Intuitive Surgical had the 13th highest net in-flow for the day. Intuitive Surgical traded down ($2.39) for the day and closed at $421.37

ISRG has been the subject of a number of research reports. Wedbush restated a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 10th. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price target for the company in a report on Tuesday, December 12th. Goldman Sachs Group restated a “buy” rating on shares of Intuitive Surgical in a report on Saturday, November 18th. Barclays restated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, October 20th. Finally, BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 12th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $357.44.

The firm has a market capitalization of $47,210.00, a price-to-earnings ratio of 54.44, a PEG ratio of 5.33 and a beta of 0.47.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.78. The firm had revenue of $806.10 million during the quarter, compared to analysts’ expectations of $753.25 million. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.20%. The business’s revenue was up 18.0% on a year-over-year basis. During the same period last year, the company earned $2.06 earnings per share. equities analysts expect that Intuitive Surgical, Inc. will post 7.85 EPS for the current year.

In related news, COO Salvatore Brogna sold 6,082 shares of the business’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $397.61, for a total transaction of $2,418,264.02. Following the transaction, the chief operating officer now directly owns 3,096 shares in the company, valued at $1,231,000.56. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Marshall Mohr sold 6,000 shares of the business’s stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $372.22, for a total transaction of $2,233,320.00. Following the transaction, the chief financial officer now owns 12,316 shares in the company, valued at $4,584,261.52. The disclosure for this sale can be found here. Insiders have sold 55,944 shares of company stock valued at $21,432,971 over the last quarter. Corporate insiders own 2.20% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. American National Bank boosted its holdings in Intuitive Surgical by 200.0% during the fourth quarter. American National Bank now owns 300 shares of the medical equipment provider’s stock worth $109,000 after purchasing an additional 200 shares during the last quarter. ETF Managers Group LLC purchased a new position in Intuitive Surgical during the second quarter worth about $110,000. Harvest Fund Management Co. Ltd purchased a new position in Intuitive Surgical during the second quarter worth about $120,000. Parallel Advisors LLC boosted its holdings in Intuitive Surgical by 195.6% during the third quarter. Parallel Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $184,000 after purchasing an additional 311 shares during the last quarter. Finally, Lincoln National Corp purchased a new position in Intuitive Surgical during the third quarter worth about $200,000. Institutional investors and hedge funds own 32.80% of the company’s stock.

WARNING: “Traders Buy Intuitive Surgical (ISRG) on Weakness” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://stocknewstimes.com/2018/01/11/traders-buy-intuitive-surgical-isrg-on-weakness.html.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply